MILLENNIUM MANAGEMENT LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$5,874,148
+19.2%
5,994,029
+69.0%
0.00%
+50.0%
Q2 2023$4,929,949
+74157.4%
3,546,726
-15.1%
0.00%
-33.3%
Q1 2023$6,639
-56.9%
4,175,274
+68.7%
0.00%
-66.7%
Q4 2022$15,415
-99.9%
2,474,309
+43.6%
0.01%
+28.6%
Q3 2022$11,545,000
-32.9%
1,723,175
-36.3%
0.01%
-36.4%
Q2 2022$17,212,000
+197.2%
2,706,290
+116.8%
0.01%
+266.7%
Q1 2022$5,792,000
+246.4%
1,248,338
+273.3%
0.00%
+200.0%
Q4 2021$1,672,000
-70.3%
334,430
-28.4%
0.00%
-66.7%
Q3 2021$5,631,000
-16.0%
467,298
+47.4%
0.00%
-25.0%
Q2 2021$6,703,000
-35.9%
316,933
-14.9%
0.00%
-42.9%
Q1 2021$10,452,000
+189.1%
372,614
+168.0%
0.01%
+133.3%
Q4 2020$3,615,000
-69.2%
139,041
-56.0%
0.00%
-78.6%
Q3 2020$11,751,000
-63.6%
316,133
-49.8%
0.01%
-68.2%
Q2 2020$32,281,000
+1102.3%
629,139
+638.7%
0.04%
+633.3%
Q1 2020$2,685,000
-82.6%
85,165
-67.0%
0.01%
-68.4%
Q4 2019$15,394,000
+412.3%
258,151
+214.9%
0.02%
+280.0%
Q3 2019$3,005,000
-71.1%
81,987
-63.3%
0.01%
-66.7%
Q2 2019$10,406,000
-27.6%
223,684
-37.5%
0.02%
-31.8%
Q1 2019$14,381,000
+278.7%
358,173
+334.0%
0.02%
+266.7%
Q4 2018$3,797,000
+168.0%
82,536
+158.4%
0.01%
+200.0%
Q3 2018$1,417,000
-58.3%
31,937
-63.2%
0.00%
-50.0%
Q2 2018$3,402,000
-65.0%
86,817
-35.5%
0.00%
-69.2%
Q1 2018$9,729,000
-61.9%
134,503
-65.3%
0.01%
-62.9%
Q4 2017$25,542,000
+1427.6%
387,947
+1062.7%
0.04%
+1066.7%
Q3 2017$1,672,000
+450.0%
33,367
+407.9%
0.00%
+200.0%
Q2 2017$304,000
-72.9%
6,570
-79.3%
0.00%
-50.0%
Q1 2017$1,121,000
-44.1%
31,761
-80.2%
0.00%
-50.0%
Q4 2016$2,006,000
+94.2%
160,195
+114.7%
0.00%
+100.0%
Q3 2016$1,033,000
-45.3%
74,598
-33.1%
0.00%
-60.0%
Q1 2016$1,887,000
-12.3%
111,577
+15.5%
0.01%0.0%
Q4 2015$2,151,000
-60.3%
96,609
+65.3%
0.01%
-50.0%
Q1 2015$5,412,000
+1411.7%
58,444
+559.5%
0.01%
+900.0%
Q4 2014$358,000
-80.5%
8,862
-88.2%
0.00%
-80.0%
Q3 2014$1,835,000
+48.2%
75,036
-4.0%
0.01%
+66.7%
Q2 2014$1,238,000
+4.7%
78,1810.0%0.00%0.0%
Q1 2014$1,182,000
+43.4%
78,181
+30.3%
0.00%0.0%
Q4 2013$824,00060,0000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders